Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-8.14x3.89x-0.2x3.48x-6.33x-5.98x-.--% 2.05B
18.09x2.32x11.23x4.11x9.64x11.42x0.51% 76.15B
36.16x7.44x0.67x12.36x23.52x27.52x-.--% 47.83B
23.38x3.6x1.44x4.96x14.7x17.81x0.66% 48.89B
-46.27x2.57x0.36x3.25x9.61x11.21x3.29% 41.37B
37.23x1.65x-0.98x3.37x12.07x13.84x-.--% 29.99B
55.01x4.08x-0.83x3.36x26.05x23.16x-.--% 24.23B
-6.28x4.31x-0.31x8.82x-5.47x-5.15x-.--% 21.75B
63.91x5.61x0.43x6.1x41.98x48.5x-.--% 19.25B
24.69x3.63x0.02x5.29x13.78x19.15x-.--% 17.14B
-36x-6.39x0.87x17.16x-46.97x-54.28x-.--% 15.66B
-105.74x11546.08x2.4x11.35x-81.23x-113.22x-.--% 11.22B
17.77x - 0.2x3.64x14.09x16.45x-.--% 11.6B
45.68x - 4.98x - - - -.--% 10.06B
56.44x23.02x0.53x34.19x48.35x49.87x0.17% 11.5B
12.69x1.17x0.38x1.89x7.64x10.3x2.76% 6.84B
58.85x7.27x0.86x5.73x31.69x42.68x-.--% 5.8B
29.58x - 1.45x7.98x21.16x25.28x0.35% 6.06B
-116.26x - 7.7x - - - -.--% 5.73B
-45.23x - -0.81x - - - - 5.7B
Average 5.78x 774.02x 1.52x 8.06x 7.90x 8.15x 0.41% 20.94B
Weighted average by Cap. 13.21x 344.98x 2.58x 7.04x 10.87x 11.95x 0.56%
Biopharmaceuticals